-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Collegium Pharmaceutical, Maintains $50 Price Target

Benzinga·03/24/2025 12:08:01
Listen to the news
HC Wainwright & Co. analyst Oren Livnat reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and maintains $50 price target.